Catalyst Wire Dossier Catalyst Wire Dossier

Takhzyro

lanadelumab · Takeda
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Takhzyro, covering 2018-08-23 to 2026-08-20. Get the full timeline:

Most recent: FDA Approved: TAKHZYRO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

See pricing